New York Life Investment Management LLC Horizon Therapeutics Public LTD CO Transaction History

New York Life Investment Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	BUY	$98.98 - $115.74 $910,714 - $1.06 Million	9,201 Added 3.55%	268,034 $31 Million
Q2 2023 Aug 04, 2023	BUY	$96.34 - $112.38 $419,175 - $488,965	4,351 Added 1.71%	258,833 $26.6 Million
Q1 2023 May 08, 2023	BUY	$107.32 - $113.5 $26.8 Million - $28.4 Million	249,963 Added 5531.38%	254,482 $27.8 Million
Q4 2022 Feb 10, 2023	SELL	$62.39 - $113.8 $20,963 - $38,236	-336 Reduced 6.92%	4,519 $514,000
Q3 2022 Nov 10, 2022	SELL	$58.92 - $84.67 $3,299 - $4,741	-56 Reduced 1.14%	4,855 $300,000

Q2 2022 Aug 12, 2022	BUY	$79.4 - $116.36 $389,933 - $571,443	4,911 New	4,911 $392,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of New York Life Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on New York Life Investment Management LLC with notifications on news.